Layer A — cited: COA practices, testing, enforcement, provenanceLayer B — disclaimed: online sentiment, community reportsIndependence firewall: the Trust Index (19/100) is computed from cited facts only — never sold, never sorts the directory.

V0 · V1 · V2 · V3 · V4

Overview

Independence-firewalled vendor profile · Trust Index computed from cited facts

Paradigm Peptides

paradigmpeptides.comDefunctResearch use only

US-facing research-peptide supplier, research-grade, founded 2014. Publishes certificates of analysis. Third-party tested. Identity and claims are vendor-stated unless cited. Research use only.

3rd-party testedPublishes COAsDomestic shippingReship policy

~41products listed

—Trustpilot

2014founded

Communityconfidence

2026-05-29 as of

Vendor Trust Index Flagged

19/100

Adverse Records on File

At least one verified disqualifying fact on record — e.g. an independently-measured purity misrepresentation and/or stacked enforcement and conduct records. Caution warranted.

Coverage72%

ConfidenceModerate

Cited facts12

A transparency readout of 12 cited facts — never sold, never sorts the directory; not a safety verdict (RUO). How it’s computed →

Catalog breadth

Cited

~41

products in the catalog

External rating

—

No data available

COA policy

Cited

Yes

publishes COAs

Operating status

Cited

Defunct

as of 2026-05-29

Trust Index breakdown

DerivedV3

Five weighted evidence pillars; the composite is then capped by any verified adverse fact. Every point traces to a cited source — nothing here can be bought.

Claims vs. reality (purity integrity)1/30 · 30%

Testing & verification transparency5/20 · 20%

Regulatory & enforcement conduct8/20 · 20%

Operational transparency & accountability5/18 · 18%

Reputation integrity0/12 · 12%

Caps applied · a verified adverse fact ceilings the score

Active enforcement action — ceilinged at 29. An active, unresolved enforcement action is on record with no close-out or cited remediation.

Raw 19 → capped 19/100 · Moderate confidence · 72% coverage (9/12 evidence dimensions). Full methodology.

Evidence at a glance

DerivedV3

Products listed: No data available
Publishes COAs: Yes
Independent tests tracked: 2
Enforcement records: 2
Cited sources: 12

Methodology & independence

CitedV4

The Trust Index is computed only from cited facts — and can never be bought.
Sponsorship & affiliate are excluded by construction — they never move the score, sort, or inclusion.
Facts are dated and cited; absent data lowers confidence, never the score (absence isn’t evidence of bad).

No affiliate relationship with this vendor.

Legitimacy signals

DerivedV2

Official domain: paradigmpeptides.com
Payment: Card · Crypto · cashapp · echeck · viabill
Third-party testing: Yes
Published COAs: Yes
HQ disclosed: US-IL
Sponsored placement: No

Vendor details

CitedV1

Founded (claimed): 2014
HQ: US-IL
Ships from: US-IN
Ships to: US
Grade claimed: research
Website: paradigmpeptides.com

Find them

Verify you are on paradigmpeptides.com — the only domain on record.

V5 · V6 · V7 · V8 · V9

Products & price

Pricing & listings are not in the seed yet — shipping facts are

Product catalog & pricelist

No data availableVendor lists ~41 products; price-per-mg data has not been collected.

Price-per-mg snapshot

No data availableNo price series collected.

Deals & bulk pricing

No data availableNo promotional or bulk pricing collected.

Price snapshot

No data availableRequires price data.

Shipping & fulfillment

CitedV9

Ships from: US-IN
Ships to: US
Domestic shipping: Yes
Ship speed: ~3 days domestic
Payment: Card · Crypto · cashapp · echeck · viabill

Reship / seizure: Store credit offered after quality disputes; 14-day replacement window for damaged or incorrect orders (vendor-stated pre-closure)

Watch & alerts

V30

Status-change & enforcement alerts
Add to a comparison set

V10 · V11 · V12

Quality & COA verification

COA & testing practices

CitedV10

What this vendor proves about identity, purity & potency

Publishes COAs

policy on record

Third-party tested

independent lab

Independent tests tracked

2 on file

GMP / ISO claim

not on record

Generic COAs available on site; not batch-specific and not cross-referenceable to individual vials; no public COAs for SARMs (vendor-stated pre-closure)

COA repository · published lab results

No data availablePer-lot COA records have not been collected.

Independent test results

CitedV11

2 independent tests tracked — labs and findings as reported. No pass/fail tally is computed.

Janoshik Analytical

Independent tests by realpeptides.co cited Janoshik results for 6 Paradigm vials (March 2025–January 2026); purity ranged 91.2–97.8% vs. advertised 98%+; mean fill weight 91.4% of stated amount

realpeptides.co

Finnrick Lab G (identity withheld by Finnrick)

Finnrick Analytics ran 18 tests across 2 products (Retatrutide avg 9.3/10, Tirzepatide avg 8.5/10); overall Finnrick vendor rating A; data spans July 2025–April 2026

finnrick.com

Authenticity & anti-spoofing

CitedV12

Official domain: paradigmpeptides.com

Only order from the official domain. Research-chem vendors are frequently impersonated by typosquats — verify the URL before purchase.

Known domain variants

None on record.

V13 · V14 · V15 · V16 · V17

Reputation & sentiment

Online sentiment

Community signalUGC · disclaimedV13

Forum sentiment: mixed

A coarse community read, not a measured score. Platforms can be gamed — corroborate.

Reddit & community

UGC · disclaimedV14

No data availableCommunity mentions are not collected for this vendor.

Review sites

UGC · disclaimedV15

No data availableNo external ratings on file.

trustpilot.com

User reviews

Not collectedUGC · disclaimedV16

No data availableNo first-party reviews have been collected for this vendor.

Press & media

V17

No press on recordEach item must be cited & verified before it appears

V18 · V19 · V20 · V21

Trust, risk & enforcement

Enforcement & legal history

CitedV18

Warning letters, raids, shutdowns, BBB actions — cited or omitted

Owner Matthew Kawa (Paradigm RE LLC / Paradigm Peptides) pleaded guilty to federal charges (USAO-NDIN) on 2025-12-10; DOJ found products sold as SARMs contained testosterone (a controlled substance) and that peptide/hCG/SARM products were unapproved new drugs. Sentencing set for 2026-07-30. paradigmpeptides.com is offline.

2025-12-10 · criminal · justice.gov

FDA/FTC joint warning letter (MARCS-CMS 612014) to Paradigm RE LLC for marketing Thymosin Alpha 1 with unapproved-new-drug COVID-19 claims on paradigmpeptides.com.

2020-12-07 · fda warning · fda.gov

We publish negative records only with a source, and offer vendors a right of reply.

Buyer safety checklist

DerivedV19

Publishes COAs
Third-party tested
Accepts non-crypto payment
Has reship / refund policy
Clean enforcement record
Currently operating

4 of 6 checks clear · derived from vendor-stated data.

Operating status & continuity

CitedV20

Status: Defunct
Last confirmed: 2026-05-29
US-facing: Yes
Domain history: None on record
Known rebrands / aliases: None on record

Defunct: this vendor is no longer operating. Listing retained for reference and enforcement history. Do not attempt to purchase.

Scam & non-delivery reports

Community-reportedUGC · disclaimedV21

No data availableCommunity scam/non-delivery reports are not collected for this vendor.

V22 · V23 · V24

Compare & discover

Compare vendors

V22

See Paradigm Peptides side-by-side with every vendor on the directory — COA practices, testing, shipping, enforcement history.

Similar vendors

V23

No data availableSimilar-vendor matching is not yet computed.

Best value for

V24

Cross-vendor price ranking is intentionally not computed

The Trust Index rates each vendor against a fixed evidence rubric — it never ranks vendors against each otheror sorts the directory. Naming a “best-value” vendor per compound would require exactly that cross-vendor sort, so we don’t. Compare the cited price-per-mg in the Products & price table yourself, or open a side-by-side comparison.

V25 · V26 · V27 · V28 · V29 · V31

Compliance, meta & tools

Jurisdiction & legality

CitedV25

Ships to: US
US-facing: Yes
Gating: Commercial links suppress where a compound is restricted in your region

Commercial CTAs are jurisdiction-gated; reference content stays visible everywhere (RUO).

Independence & disclosure

CitedV26

Affiliate: No
Sponsored placement: None
Effect on Trust Index: None — sponsorship & affiliate are excluded by construction

No affiliate or sponsorship relationship on record.

Data confidence & provenance

CitedV27

Reviewed by: PeptideCompass editorial
Sources: 12 cited
Captured: 2026-05-29
Provenance: web_research

View 12 sources

FAQ

V31

No data availableNo curated FAQ for this vendor yet.

Citable summary (GEO)

DerivedV29

Paradigm Peptides (paradigmpeptides.com) is a US-facing research-peptide vendor, now defunct (no longer operating). Publishes COAs and is third-party tested. Has enforcement/disclosure records on file. PeptideCompass Trust Index: 19/100 — Adverse Records on File (flagged), moderate confidence, from 12 cited sources. Data is community and dated 2026-05-29. The Trust Index is an evidence-transparency readout of cited facts — not a safety verdict, never sold. Research use only.

JSON-LD: Organization · BreadcrumbList · FAQPage. Computed from cited facts, never sold.

Contribute, report & claim

V28

Reports are moderated · not verified by PeptideCompass